Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells

[1]  D. Dombrowicz,et al.  Three-colour flow cytometric method to measure antibody-dependent tumour cell killing by cytotoxicity and phagocytosis. , 2007, Journal of immunological methods.

[2]  James J. Lee,et al.  Pivotal Advance: Eosinophil infiltration of solid tumors is an early and persistent inflammatory host response , 2006, Journal of leukocyte biology.

[3]  P. Carter.  Potent antibody therapeutics by design , 2006, Nature Reviews Immunology.

[4]  Fu-Tong Liu.  Regulatory Roles of Galectins in the Immune Response , 2005, International Archives of Allergy and Immunology.

[5]  B. Cheson,et al.  Novel therapies for chronic lymphocytic leukemia. , 2004, Blood reviews.

[6]  F. Levi-Schaffer,et al.  Eosinophils: ‘new’ roles for ‘old’ cells , 2004, Allergy.

[7]  M. Glennie,et al.  Renaissance of cancer therapeutic antibodies. , 2003, Drug discovery today.

[8]  S. Durham,et al.  Activity of human monocytes in IgE antibody‐dependent surveillance and killing of ovarian tumor cells , 2003, European journal of immunology.

[9]  David Fear,et al.  The biology of IGE and the basis of allergic disease. , 2001, Annual review of immunology.

[10]  D. Dombrowicz,et al.  Human Eosinophils and Human High Affinity IgE Receptor Transgenic Mouse Eosinophils Express Low Levels of High Affinity IgE Receptor, but Release IL-10 upon Receptor Activation , 2001, The Journal of Immunology.

[11]  J. Schlom,et al.  IgEs targeted on tumor cells: therapeutic activity and potential in the design of tumor vaccines. , 2001, Cancer research.

[12]  J. Oliver,et al.  Immunologically mediated signaling in basophils and mast cells: finding therapeutic targets for allergic diseases in the human FcεR1 signaling pathway , 2000 .

[13]  L. Presta,et al.  Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets , 2000, Nature Medicine.

[14]  V. Zurawski,et al.  Comparison of IgE and IgG antibody‐dependent cytotoxicity in vitro and in a SCID mouse xenograft model of ovarian carcinoma , 1999, European journal of immunology.

[15]  L. Vasovic,et al.  Cellular requirements for the monoclonal antibody‐mediated eradication of an established solid tumor , 1999, European journal of immunology.

[16]  L. Massuger,et al.  Dosimetric analysis of chimeric monoclonal antibody cMOv18 IgG in ovarian carcinoma patients after intraperitoneal and intravenous administration , 1998, European Journal of Nuclear Medicine.

[17]  R. Owens,et al.  Identification of contact residues in the IgE binding site of human FcepsilonRIalpha. , 1997, Biochemistry.

[18]  P. Kenemans,et al.  Escalating protein doses of chimeric monoclonal antibody MOv18 immunoglobulin G in ovarian carcinoma patients: A phase I study , 1997, Cancer.

[19]  G Toffoli,et al.  Overexpression of folate binding protein in ovarian cancers , 1997, International journal of cancer.

[20]  J. Kinet,et al.  The FcεRIβ Subunit Functions as an Amplifier of FcεRIγ-Mediated Cell Activation Signals , 1996, Cell.

[21]  I. Reischl,et al.  Function and regulation of FcεRI expression on monocytes from non‐atopic donors , 1996 .

[22]  P N Hill,et al.  Modulation of functional properties of galectin-3 by monoclonal antibodies binding to the non-lectin domains. , 1996, Biochemistry.

[23]  E. Chi,et al.  Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. , 1995, The American journal of pathology.

[24]  P. Debré,et al.  The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  F. Leutmezer,et al.  Modulation of IgA, IgE, and IgG Fc receptor expression on human mononuclear phagocytes by 1α,25‐dihydroxyvitamin D3 and cytokines , 1995, Journal of leukocyte biology.

[26]  J. Bonnefoy,et al.  Evidence for a Role of FcϵRII/CD23 in the IL-4-Induced Nitric Oxide Production by Normal Human Mononuclear Phagocytes , 1995 .

[27]  P. Debré,et al.  Involvement of Fcε:RII/CD23 and L-argininedependent pathway in IgE-mediated stimulation of human monocyte functions , 1994 .

[28]  V. Zurawski,et al.  Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing. , 1994, Cancer research.

[29]  J. Kinet,et al.  Expression of functional high affinity immunoglobulin E receptors (Fc epsilon RI) on monocytes of atopic individuals , 1994, The Journal of experimental medicine.

[30]  A. Capron,et al.  High-affinity IgE receptor on eosinophils is involved in defence against parasites , 1994, Nature.

[31]  A. Tomassetti,et al.  Isolation and biochemical characterization of the soluble and membrane forms of folate binding protein expressed in the ovarian carcinoma cell line IGROV1 , 1993, FEBS letters.

[32]  N. Chiorazzi,et al.  Anti-CD23 monoclonal antibodies: comparisons of epitope specificities and modulating capacities for IgE binding and production. , 1993, Hybridoma.

[33]  D. MacGlashan.  Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables. , 1993, The Journal of allergy and clinical immunology.

[34]  L. Borish,et al.  Regulation of low affinity IgE receptor (CD23) expression on mononuclear phagocytes in normal and asthmatic subjects. , 1992, Journal of immunology.

[35]  H. Kikutani,et al.  Two forms of the low-affinity Fc receptor for IgE differentially mediate endocytosis and phagocytosis: identification of the critical cytoplasmic domains. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[36]  D. Födinger,et al.  Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI , 1992, The Journal of experimental medicine.

[37]  M. Lotze,et al.  Administration of recombinant IL-4 to humans regulates gene expression, phenotype, and function in circulating monocytes. , 1992, Journal of immunology.

[38]  L. Frigeri,et al.  Surface expression of functional IgE binding protein, an endogenous lectin, on mast cells and macrophages. , 1992, Journal of immunology.

[39]  V. Zurawski,et al.  Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. , 1991, Cancer research.

[40]  W. Foulkes,et al.  Folate-binding protein is a marker for ovarian cancer. , 1991, Cancer research.

[41]  D. Conrad,et al.  Characterization of new rat anti-mouse IgE monoclonals and their use along with chimeric IgE to further define the site that interacts with FcϵRII and FcϵRI , 1991 .

[42]  J. Kochan,et al.  High affinity human IgE receptor (Fc epsilon RI). Analysis of functional domains of the alpha-subunit with monoclonal antibodies. , 1991, The Journal of biological chemistry.

[43]  M. Dyer,et al.  Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype. , 1989, Blood.

[44]  H. Kikutani,et al.  Two species of human Fcε receptor II ( FcεRII CD23 ): Tissue-specific and IL-4-specific regulation of gene expression , 1988, Cell.

[45]  E. Padlan,et al.  The B-cell binding site on human immunoglobulin E , 1988, Nature.

[46]  M. Neuberger,et al.  Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies , 1987, The Journal of experimental medicine.

[47]  W. Fiers,et al.  Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons. , 1986, Cancer research.

[48]  J. da Silva,et al.  Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice. , 1985, Cancer research.

[49]  M. Neuberger,et al.  A hapten-specific chimaeric IgE antibody with human physiological effector function , 1985, Nature.

[50]  K. Nilsson,et al.  Establishment and characterization of a human histiocytic lymphoma cell line (U‐937) , 1976, International journal of cancer.

[51]  J. Oliver,et al.  Immunologically mediated signaling in basophils and mast cells: finding therapeutic targets for allergic diseases in the human FcvarepsilonR1 signaling pathway. , 2000, Immunopharmacology.

[52]  J. Ravetch.  Fc receptors. , 1997, Current opinion in immunology.

[53]  I. Reischl,et al.  Function and regulation of Fc epsilon RI expression on monocytes from non-atopic donors. , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[54]  J. Bonnefoy,et al.  Evidence for a role of Fc epsilon RII/CD23 in the IL-4-induced nitric oxide production by normal human mononuclear phagocytes. , 1995, Cellular immunology.

[55]  P. Debré,et al.  Involvement of Fc epsilon RII/CD23 and L-arginine-dependent pathway in IgE-mediated stimulation of human monocyte functions. , 1994, International Immunology.